PRECISIONBIOLOGICS
Menu
↗
Regulatory

cGMP

cGMP, current Good Manufacturing Practice, is the set of FDA regulations governing the methods, facilities, and controls used to manufacture, process, and package drugs and biologics so that quality is consistently assured.

cGMP requirements cover facility design and controls, personnel training, equipment qualification, written procedures, and batch recordkeeping, with the goal of making manufacturing outcomes reproducible and traceable. The requirements apply broadly across the drug and biologic industries, not to any single product category.

Ask counsel which manufacturing requirements apply to a specific product. Request the processing description and lot release documentation rather than assuming which framework governs it.

When a vendor states that a product is processed "following cGMP," a buyer should ask whether that means HCT/P-specific tissue practice regulations or full drug-level cGMP, since the two are not interchangeable. Requesting the underlying lot release and testing records behind that claim is a more useful verification step than relying on the acronym alone.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

cGMP and HCT/P tissue-practice rules are not the same thing, so a buyer should clarify which framework a vendor is actually describing before relying on the claim.

Sources

  1. 21 CFR 1271.10 - Are my HCT/Ps regulated solely under section 361 of the PHS Act ↗eCFR
  2. Consumer alert on regenerative medicine products including stem cells and exosomes ↗FDA